Analysis of PPARGC1B, RUNX3 and TBKBP1 Polymorphisms in Chinese Han Patients with Ankylosing Spondylitis: A Case-Control Study

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Lian, Zijian ^a,b,c   Chai, Wei ^a   Shi, Lewis L ^d   Chen, Chao ^a,c   Liu, Jingyi ^b   Wang, Yan ^a,b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NANKAI UNIVERSITY   (China)

^c TIANJIN HOSPITAL   (China)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; TRANSCRIPTION FACTOR RUNX3;

ADOLESCENT; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PPARGC1B GENE; RUNX3 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TBKBP1 GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CARRIER PROTEINS; CASE-CONTROL STUDIES; CORE BINDING FACTOR ALPHA 3 SUBUNIT; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SPONDYLITIS, ANKYLOSING;

EID: 84876321689     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061527     Document Type: Article

References (48)

1. Brown MA, Wordsworth BP, Reveille JD, (2002) Genetics of ankylosing spondylitis. Clin Exp Rheumatol 20: S43-9.
2. Braun J, Sieper J, (2007) Ankylosing spondylitis. Lancet 369: 1379-90.
3. Carette S, Graham D, Little H, Rubenstein J, Rosen P, (1983) The natural disease course of ankylosing spondylitis. Arthritis Rheum 26: 186-90.
4. Gran JT, Skomsvoll JF, (1997) The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 36: 766-71.
5. Wanders A, Landewé R, Spoorenberg A, de Vlam K, Mielants H, et al. (2004) Scoring of radiographic progression in randomised clinical trials in ankylosing spondylitis: a preference for paired reading order. Ann Rheum Dis. Dec;63(12): 1601-4. Epub Aug 5.
6. Hamersma J, Cardon LR, Bradbury L, Brophy S, van der Horst-Bruinsma I, et al. (2001) Is disease severity in ankylosing spondylitis genetically determined?.
7. The Australo-Anglo-American Spondyloarthritis Consortium (TASC) & the Wellcome Trust Case Control Consortium (WTCCC) (2007) Association scan of 14,500 nsSNPs in four common diseases identifies variants involved in autoimmunity. Nat Genet. 39(11): 1329-1337.
8. The Australo-Anglo-American Spondyloarthritis Consortium (TASC) & the Wellcome Trust Case Control Consortium (WTCCC) (2011) Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nature Genetics volume 43 number 8 August.
9. Sirota M, Schaub MA, Batzoglou S, Robinson WH, Butte AJ, (2009) Autoimmune Disease Classification by Inverse Association with SNP Alleles PLoS Genet. Dec 5(12): e1000792.
10. Lehne B, Lewis CM, Schlitt T (2011) From SNPs to genes: disease association at the gene level. PLoS ONE June, Volume 6, Issue 6, e20133.
11. van der Linden S, Valkenburg HA, Cats A, (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 27: 361-368.
12. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of Bath ankylosing spondylitis disease functional index (BASFI). J Rheumatol 21: 2281-2285.
13. Garrett S, Jenkinson TR, Whitelock HC, Kennedy LG, Gaisford P, et al. (1994) A new approach to defining disease status in AS: the Bath ankylosing spondylitis disease activity index (BASDAI). J Rheumatol 21: 2286-2291.
14. Baraliakos X, Listing J, von der Recke A, Braun J, (2009) The natural course of radiographic progression in ankylosing spondylitis-evidence for major individual variations in a large proportion of patients. J Rheumatol 36: 997-1002.
15. Creemers MC, Franssen MJ, van't Hof MA, Gribnau FW, van de Putte LB, et al. (2005) Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 64: 127-9.
16. Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, et al. (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl II): 1-44.
17. Amor B, Santos RS, Nahal R, Listrat V, Dougados M, (1994) Predictive factors for the longterm outcome of spondyloarthropathies. J Rheumatol 21: 1883-87.
18. Kiaer T, Gehrchen M, (2010) Transpedicular closed wedge osteotomy in ankylosing spondylitis: results of surgical treatment and prospective outcome analysis. Eur Spine J 19: 57-64.
19. Tost J, Gut IG, (2005) Genotyping single nucleotide polymorphisms by MALDI mass spectrometry in clinical applications. Clinical Biochemistry 38: 335-350.
20. Reveille JD, Ball EJ, Khan MA, (2001) HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr.Opin. Rheumatol. 13: 265-272.
21. Taylor AL, Balakrishnan C, Calin A (1998) Reference centile charts for measures of disease activity, functional imparirment, and metrology in ankylosing spongdylitis. Arthritis & Rheumatism Vol 41. No 6. June. 1119-1125.
22. Braun J, van der Heijde D, Dougados M, Emery P, Khan MA, et al. (2002) Staging of patients with ankylosing spondylitis: a preliminary proposal. Ann Rheum Dis Dec 61Suppl 3: iii9-23.
23. Sirota M, Schaub MA, Batzoglou S, Robinson WH, Butte AJ (2009) Autoimmune disease classification by Inverse association with SNP alleles. PLoS genetics December, Volume 5, Issue 12, e1000792.
24. Vionnet N, Hani EH, Dupont S, Gallina S, Francke S, et al. (2000) Genome wide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67: 1470-80.
25. Wirtenberger M, Tchatchou S, Hemminki K, Schmutzhard J, Sutter C, et al. (2006) Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer. Carcinogenesis 27: 2201-2208.
26. Puigserver P, Wu Z, Park CW, Graves R, Wright M, et al. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis, Cell. 92: 829-839.
27. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, et al. (2000) Peroxisome proliferator-activated receptor coactivator-1 promotes cardiac mitochondrial biogenesis, J. Clin. Invest. 106: 847-856.
28. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, et al. (2001) Spiegelman, Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1, Nature. 413: 131-138.
29. Herzig S, Long F, Jhala US, Hedrick S, Quinn R, et al. (2001) CREB regulates hepatic gluconeogenesis through the coactivator PGC-1, Nature. 413: 179-183.
30. Vega RB, Huss JM, Kelly DP, (2000) The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor a in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes, Mol. Cell. Biol. 20: 1868-1876.
31. Dimauro S, Schon EA, (2008) Mitochondrial disorders in the nervous system. Annu. Rev. Neurosci. 31: 91-123.
32. Srivastava S, Diaz F, Iommarini L, Aure K, Lombes A, et al. (2009) PGC-1 1alpha/beta induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders. Human Molecular Genetics, Vol. 18 10: 1805-1812.
33. Ishii KA, Fumoto T, Iwai K, Takeshita S, Ito M, et al. (2009) Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med. Mar;15(3): 259-66. Epub 2009 Mar 1.
34. Derynck R, Akhurst RJ, Balmain A, (2001) TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29: 117-29.
35. Li QL, Ito K, Sakakura C, (2002) Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109: 113-24.
36. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, et al. (2005) RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res 65: 7743-50.
37. Fujii S, Ito K, Ito Y, Ochiai A, (2008) Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation. J Biol Chem 283: 17324-32.
38. Subramaniam MM, Chan JY, Yeoh KG, Quek T, Ito K, et al. (2009) Molecular pathology of RUNX3 in human carcinogenesis. Biochim Biophys Acta 1796: 315-331.
39. Goel A, Arnold CN, Tassone P, Chang DK, Niedzwiecki D, et al. (2004) Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers. Int J Cancer 112: 754-9.
40. Li QL, Kim HR, Kim WJ, Choi JK, Lee YH, et al. (2004) Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem Biophys Res Commun 314: 223-8.
41. Lau QC, Raja E, Salto-Tellez M, Liu Q, Ito K, et al. (2006) RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res 66: 6512-20.
42. Alarcón-Riquelme ME, (2004) Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus. Arthritis Res. Ther. 6: 169-173.
43. Klunker S, Chong MM, Mantel PY, Palomares O, Bassin C, et al. (2009) Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J Exp Med 206(12): 2701-2715.
44. Wu Y, Ren M, Yang R, Liang X, Ma Y, et al. (2011) Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+Th/Treg cell subset imbalance in ankylosing spondylitis. Arthritis Res Ther 13(1): R29.
45. Fainaru O, Woolf E, Lotem J, Yarmus M, Brenner O, et al. (2004) Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J. 23: 969-979.
46. Unterholzner L, Sumner RP, Baran M, Ren H, Mansur DS, et al. (2011) Vaccinia Virus Protein C6 Is a Virulence Factor that Binds TBK-1 Adaptor Proteins and Inhibits Activation of IRF3 and IRF7 PLoS pathogens Sep;7(9): e1002247. Epub 2011 Sep 8.
47. Ishii KJ, Kawagoe T, Koyama S, Matsui K, Kumar H, et al. (2008) TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature. Feb 7 451(7179): 725-9.
48. Reveille JD, Ball EJ, Khan MA, (2001) HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr.Opin. Rheumatol. 13: 265-272.